Strata Critical Medical, Inc. (SRTA) stock
SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3037% below fair value
$5.51−0.26 (-4.51%)
Close on Nov 13, 2026Market cap $487.45MP/E 10.8Yield –
Strata Critical Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Strata Critical Medical's ebitda for the twelve months ending Jun 30, 2026 was -$4.12M. For fiscal 2025 it was -$14.17M. The highest annual figure on record is -$9.83M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.17M | – |
| FY2024 | Dec 31, 2024 | -$16.56M | – |
| FY2023 | Dec 31, 2023 | -$61.01M | – |
| FY2021 | Sep 30, 2021 | -$23.50M | – |
| FY2020 | Sep 30, 2020 | -$9.83M | – |
| FY2019 | Sep 30, 2019 | -$11.07M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $3.11M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $86.00K | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$3.40M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$3.92M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$2.87M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$3.99M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$4.37M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$5.81M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$10.59M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$8.27M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$33.83M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$5.61M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$10.40M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$11.18M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$9.54M | – |
See a number that looks wrong?